Cumberland Pharmaceuticals Inc. (CPIX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cumberland Pharmaceutical...

    NASDAQ: CPIX · Real-Time Price · USD
    2.98
    -0.25 (-7.74%)
    At close: Sep 23, 2025, 3:59 PM
    2.98
    0.00%
    After-hours: Sep 23, 2025, 05:05 PM EDT

    Cumberland Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 37.87M 39.55M 42.01M 35.99M
    Cost of Revenue
    		 6.59M 6.07M 9.12M 8.81M
    Gross Profit
    		 31.28M 33.49M 32.89M 27.17M
    Operating Income
    		 -6.43M -6.21M -5.7M -7.68M
    Interest Income
    		 334.44K 286.85K 98.41K 26.08K
    Pretax Income
    		 -6.47M -6.28M -5.58M -5.56M
    Net Income
    		 -6.48M -6.28M -5.65M -5.6M
    Selling & General & Admin
    		 28.15M 29.1M 26.84M 24.8M
    Research & Development
    		 4.82M 5.83M 6.69M 5.68M
    Other Expenses
    		 4.75M 8.1M 5.07M 4.37M
    Operating Expenses
    		 37.71M 43.04M 38.6M 34.85M
    Interest Expense
    		 605.51K 667.86K 586K 98.03K
    Selling & Marketing Expenses
    		 17.02M 18.45M 16.66M 15.02M
    Cost & Expenses
    		 44.3M 49.11M 47.72M 43.66M
    Income Tax Expense
    		 -22.67K 45.77K 68.85K 34.89K
    Shares Outstanding (Basic)
    		 14.06M 14.3M 14.56M 14.9M
    Shares Outstanding (Diluted)
    		 14.06M 14.3M 14.56M 14.9M
    EPS (Basic)
    		 -0.46 -0.44 -0.39 -0.38
    EPS (Diluted)
    		 -0.46 -0.44 -0.39 -0.38
    EBITDA
    		 182.42K 153.32K 332.92K -857.83K
    EBIT
    		 -5.86M -5.62M -5M -5.46M
    Depreciation & Amortization
    		 6.04M 5.77M 5.33M 4.61M

    Add to Watchlist